Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Source filing unavailable
Q4 2011 · —
Revenue$10.38B$10.38B+4.1% vs Q4 2010 Net Income$1.62B$1.62B+12.3% vs Q4 2010 EPS Diluted$1.02$1.02+10.9% vs Q4 2010 Gross Profit$6,539,600,000+10.4% Operating Incomederived-$2,040,480,000N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flowderived$1,401,272,000−39.5% Free Cash Flowderived$1,127,037,000−44.3% Margins · derivedGross margin63.0%+3.6 pt vs Q4 2010
Operating margin-19.7%−38.0 pt vs Q4 2010
Net margin15.6%+1.1 pt vs Q4 2010